Miracle Mile Advisors’s Altimmune ALT Stock Holding History

Miracle Mile Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.7K	Hold	17,000	–	–	﹤0.01%	1001
2026 Q1	$52.4K	Sell	17,000 -20	-0.1%	-$85	﹤0.01%	886
2025 Q4	$61.4K	Hold	17,020	–	–	﹤0.01%	858
2025 Q3	$64.2K	Sell	17,020 -19	-0.1%	-$73	﹤0.01%	815
2025 Q2	$65.9K	Buy	17,039 +39	+0.2%	+$211	﹤0.01%	712
2025 Q1	$85K	Hold	17,000	–	–	﹤0.01%	634
2024 Q4	$123K	Hold	17,000	–	–	﹤0.01%	617
2024 Q3	$104K	Hold	17,000	–	–	﹤0.01%	510
2024 Q2	$113K	Hold	17,000	–	–	﹤0.01%	482
2024 Q1	$173K	Hold	17,000	–	–	﹤0.01%	481
2023 Q4	$191K	Hold	17,000	–	–	0.01%	465
2023 Q3	$44.2K	Buy	+17,000	New	+$48.8K	﹤0.01%	476

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Miracle Mile Advisors's ALT Position: Q2 2026 in Review

Miracle Mile Advisors held its Altimmune (ALT) position steady in Q2 2026 at 17,000 shares worth $51.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Miracle Mile Advisors first reported a position in ALT in Q3 2023 and has held it in 12 quarters since. The position peaked at $191K in Q4 2023. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Miracle Mile Advisors held 17,000 shares of Altimmune worth $51.7K as of Q2 2026.
Miracle Mile Advisors left its Altimmune share count unchanged in Q2 2026.
Altimmune made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #1001 holding.
Miracle Mile Advisors first reported a position in Altimmune in Q3 2023 and has held it in 12 quarters since.
Miracle Mile Advisors's Altimmune position peaked at $191K in Q4 2023.
211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.